XML 63 R49.htm IDEA: XBRL DOCUMENT v3.25.2
SHAREHOLDERS' EQUITY (Details Textual)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 25, 2025
$ / shares
shares
Jan. 07, 2025
$ / shares
shares
Mar. 15, 2024
shares
Mar. 31, 2024
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
shares
Dec. 31, 2015
$ / shares
Jun. 30, 2025
₪ / shares
Jun. 30, 2025
USD ($)
shares
Mar. 07, 2025
USD ($)
Dec. 31, 2024
₪ / shares
shares
Dec. 28, 2016
USD ($)
Shareholders' Equity                          
Reverse share split, description       one-for-seven reverse share split of the Company’s ordinary shares     a reverse share split within a range of 1:2 to 1:12, to be effective at the ratio            
Maximum number of authorized ordinary shares reverse share split             120,000,000            
Issued and outstanding ordinary shares of reverse pre-split shares       60,100,000                  
Issued and outstanding ordinary shares of reverse post-split shares       8,600,000                  
Authorized number ordinary shares of reverse post-split shares     25,000,000                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term           6 years 9 months              
Number of share-based outstanding                   404,551   4,573  
Per share value of stock repurchase authorized | ₪ / shares                 ₪ 1.75     ₪ 1.75  
Minimum [Member]                          
Shareholders' Equity                          
Authorized number ordinary shares of reverse post-split shares     30,000,000                    
Maximum [Member]                          
Shareholders' Equity                          
Authorized number ordinary shares of reverse post-split shares     43,750,000                    
Certain institutional purchasers [Member] | Registered direct offering of ordinary shares in July 2020 [Member]                          
Shareholders' Equity                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                   288,634      
Proceeds from Warrant Exercises | $           $ 3,556,976              
Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]                          
Shareholders' Equity                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                   514,010      
Proceeds from Warrant Exercises | $           4,821,416              
Placement agent [Member] | December 2020 private placement [Member]                          
Shareholders' Equity                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                   32,283      
Proceeds from Warrant Exercises | $           $ 405,003              
Purchase agreement with certain institutional investors [Member]                          
Shareholders' Equity                          
Offering price per share | $ / shares $ 0.65 $ 2.75                      
Issuance of ordinary shares (in shares) 4,000,000 1,818,183                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 4,000,000 1,818,183                      
Purchase agreement for issuance and sale of ordinary shares and ordinary warrants                          
Shareholders' Equity                          
Exercise price per share | $ / shares   $ 2.75                      
Kreos Capital V [Member]                          
Shareholders' Equity                          
Exercise price per share | $ / shares               $ 52.5          
Warrants grant date               Dec. 31, 2015          
Warrants exercisable, description.           immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company’s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction.              
Drawdown amount under loan agreement | $                         $ 8,000,000
H.C. Wainwright & Co. LLC | Purchase agreement with certain institutional investors [Member]                          
Shareholders' Equity                          
Exercise price per share | $ / shares $ 0.8125 $ 3.4375                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 240,000 109,091                      
H.C. Wainwright & Co. LLC | At-the-Market (ATM) Offering Agreement [Member]                          
Shareholders' Equity                          
Amount reserved for future issuance | $                   $ 4,200,000      
Offering price per share | $ / shares         $ 1.3 $ 1.3              
Issuance of ordinary shares (in shares)         964,118 964,118              
Fees and other related expenses | $         $ 200,000 $ 200,000              
Net aggregate proceeds of after deducting fees and other related expenses | $         1,000,000 1,000,000              
Aggregate offering price | $                     $ 5,500,000    
Issuance of ordinary shares in an ATM offering of ordinary shares, gross of issuance expenses | $         1,300,000 1,300,000              
Fixed commission amount | $         $ 100,000 $ 100,000              
Employee Stock Option [Member]                          
Shareholders' Equity                          
Award vesting period, description           Options to purchase ordinary shares generally vest over four years, with certain options to non-employee directors vesting quarterly over one year.              
Unrecognized cost of shares | $                   $ 1,300      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term           3 years 11 months 4 days              
Restricted Stock Units (RSUs) [Member] | Nonemployee [Member]                          
Shareholders' Equity                          
Number of share-based outstanding                   0